{"generated_at": "2026-04-23T00:11:00.273321Z", "slug": "latent_space_the_ai_engineer_podcast", "source_id": "src_latent_space_the_ai_engineer_podcast", "name": "Latent Space: The AI Engineer Podcast", "episode_count": 2, "avg_signal": 71.7, "median_signal": 71.7, "top_signal": 72.9, "latest_episode_at": "2026-04-20T16:17:17Z", "earliest_episode_at": "2026-04-15T00:31:14Z", "category_mode": "tech", "cover_image_url": "https://substackcdn.com/feed/podcast/1084089/post/194810752/3a87f1aa9c0d9002c08d675c5183aae1.jpg", "rank_score": 76.679, "episodes": [{"episode_id": "ep_latent_space_the_ai_engineer_podcast_16b3920a36ea", "episode_title": "\ud83d\udd2c Training Transformers to solve 95% failure rate of Cancer Trials \u2014 Ron Alfa & Daniel Bear, Noetik", "podcast_name": "Latent Space: The AI Engineer Podcast", "podcast_slug": "latent_space_the_ai_engineer_podcast", "source_id": "src_latent_space_the_ai_engineer_podcast", "category": "tech", "publish_date": "2026-04-20T16:17:17Z", "overall_score": 70.4, "score_breakdown": {"clarity": 70.0, "originality": 67.2, "hype_penalty": 4.0, "actionability": 50.0, "technical_depth": 80.0, "information_density": 85.0}, "podcast_cover_url": "https://substackcdn.com/feed/podcast/1084089/post/194810752/3a87f1aa9c0d9002c08d675c5183aae1.jpg", "source_link": "https://www.latent.space/p/noetik", "audio_url": "https://api.substack.com/feed/podcast/194810752/1b92bce4d49858354007a47c48e4e6d4.mp3", "listen_url": "https://www.latent.space/p/noetik", "verdict": "must_listen", "why_listen": "Gain insights into how AI can transform cancer treatment by improving patient selection and drug efficacy.", "summary": "Noetic aims to address the 95% failure rate of cancer drugs by improving patient selection through advanced AI models that analyze patient biology. By leveraging multimodal data, they seek to identify distinct cancer subtypes and match them with effective treatments, moving beyond traditional cell line testing. This innovative approach could revolutionize drug development and enhance the success of clinical trials."}, {"episode_id": "ep_latent_space_the_ai_engineer_podcast_d7653a4b08db", "episode_title": "Notion\u2019s Token Town: 5 Rebuilds, 100+ Tools, MCP vs CLIs and the Software Factory Future \u2014 Simon Last & Sarah Sachs of Notion", "podcast_name": "Latent Space: The AI Engineer Podcast", "podcast_slug": "latent_space_the_ai_engineer_podcast", "source_id": "src_latent_space_the_ai_engineer_podcast", "category": "tech", "publish_date": "2026-04-15T00:31:14Z", "overall_score": 72.9, "score_breakdown": {"clarity": 58.0, "originality": 46.7, "hype_penalty": 12.0, "actionability": 100.0, "technical_depth": 100.0, "information_density": 100.0}, "podcast_cover_url": "https://substackcdn.com/feed/podcast/1084089/post/194195821/ee214f89894a45cabf7a528470753d02.jpg", "source_link": "https://www.latent.space/p/notion", "audio_url": "https://api.substack.com/feed/podcast/194195821/10f31b379fbf657fd80757e3b4244e4f.mp3", "listen_url": "https://www.latent.space/p/notion", "verdict": "worth_your_time", "why_listen": "It goes beyond the title with direct discussion of like, it's, yeah, including: I'm still bullish on MCPs in a certain environment.", "summary": "Broadly speaking, I'm really bullish on CLIs. I think it'd be really great for when you want, like, a narrow lightweight agent."}], "category_breakdown": [{"category": "tech", "count": 2}]}